Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
8 hedge funds and large institutions have $9.02M invested in Forward Pharma A/S American Depositary Shares in 2019 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 3 closing their positions.
11% less capital invested
Capital invested by funds: $10.2M → $9.02M (-$1.13M)
20% less funds holding
Funds holding: 10 → 8 (-2)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$24.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$4.21K |
| 3 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$182 |
| 4 |
IA
IFP Advisors
Tampa,
Florida
|
+$123 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NM
Newtyn Management
New York
|
-$207K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$11K |
| 4 |
PCG
Private Capital Group
West Hartford,
Connecticut
|
-$935 |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
-$877 |
FWP Hedge Fund Activity: Q4 2019 in Review
8 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q4 2019, worth a combined $9.02M — down 11% from $10.2M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of FWP and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, adding an estimated $24.5K. The largest seller was Newtyn Management, cutting an estimated $207K.
- 8 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q4 2019, down from 10 in Q3 2019.
- Funds reported $9.02M of Forward Pharma A/S American Depositary Shares stock for Q4 2019, down 11% quarter-over-quarter.
- 2 funds opened new Forward Pharma A/S American Depositary Shares positions in Q4 2019 and 3 closed out, a net change of -1 holder.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q4 2019 was Morgan Stanley, an estimated $24.5K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q4 2019 was Newtyn Management, an estimated $207K sold.
Based on aggregated 13F filings for Q4 2019.